课题基金 / 基金详情

Molecular mechanism for the nuclear receptor degradation

Molecular mechanism for the nuclear receptor degradation
核受体降解的分子机制
批准号:
15380067
负责人:
YANAGISAWA Junn
金额:
$9.15万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

YANAGISAWA Junn的其他基金

相似基金

相关文献

中文摘要
翻译
最近的证据表明,雌激素受体α(ERα)的反式激活需要雌激素依赖性受体的泛素化和降解。在这里,我们表明,雌激素未结合(unliganded)ERα也是泛素化和降解通过泛素-蛋白酶体途径。为了研究这种泛素-蛋白酶体途径,我们纯化了未配体ERα的泛素连接酶复合物,并鉴定了含有Hsc 70相互作用蛋白(CHIP)羧基末端的蛋白复合物。CHIP优先与错误折叠的ERα结合并使其泛素化以诱导降解。配体与受体的结合诱导CHIP从ERα上解离。在CHIP-/-细胞中,未配体ERα的降解被消除,然而,观察到雌激素诱导的降解程度与CHIP+/+细胞相同。我们的研究结果表明,ERα是由两个独立的泛素-蛋白酶体途径,这是通过配体结合ERα切换。一条途径是受体反式激活所必需的,另一条途径参与受体的质量控制。
英文摘要
Recent evidence indicates that the transactivation of estrogen receptor α (ERα) requires estrogen-dependent receptor ubiquitination and degradation. Here we show that estrogen-unbound (unliganded) ERα is also ubiquitinated and degraded through an ubiquitin-proteasome pathway. To investigate this ubiquitin-proteasome pathway, we purified the ubiquitin ligase complex for unliganded ERα and identified a protein complex containing the carboxyl terminus of Hsc70-interacting protein (CHIP). CHIP preferentially bound to misfolded ERα and ubiquitinated it to induce degradation. Ligand binding to the receptor induced the dissociation of CHIP from ERα. In CHIP-/-cells, the degradation of unliganded ERα was abrogated, however, estrogen-induced degradation was observed to the same extent as in CHIP+/+ cells. Our findings suggest that ERα is regulated by two independent ubiquitin-proteasome pathways, which are switched by ligand binding to ERα. One pathway is necessary for the transactivation of the receptor and the other is involved in the quality control of the receptor.
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
Ohtake F: "Modulation of oestrogen receptor signalling by association with the activated dioxin receptor"Nature. 423. 545-550 (2003)
Ohtake F:“通过与激活的二恶英受体结合来调节雌激素受体信号”自然。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yamamoto Y: "Both N-and C-terminal transactivation functions of DNA-bound ERalpha are blocked by a novel synthetic estrogen ligand"Biochem.Biophys.Res.Commun.. 312. 656-662 (2003)
Yamamoto Y:“DNA 结合的 ERα 的 N 端和 C 端反式激活功能均被新型合成雌激素配体阻断”Biochem.Biophys.Res.Commun.. 312. 656-662 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kitagawa H: "The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome"Cell. 113. 905-917 (2003)
Kitakawa H:“染色质重塑复合物 WINAC 将核受体靶向启动子,并在威廉姆斯综合征中受损”细胞。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
BRCA1 function mediates a TRAP/DRIP complex through direct interaction with TRAP220
BRCA1 功能通过与 TRAP220 直接相互作用介导 TRAP/DRIP 复合物
DOI: --
发表时间: 2004
期刊: Oncogene 23
影响因子: --
作者: [Wada, O., Takada, I., Kato, S., et al.]
通讯作者: et al.
共 12 条
    Study for epigenetic control through cross-talk among biomolecules
    • 批准号:
      21247016
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $29.37万
    • 财政年份:
      2009
    • 负责人:
      YANAGISAWA Junn
    • 依托单位:
    Analysis of the proteolysis mechanism by nuclear receptors
    • 批准号:
      19390014
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.23万
    • 财政年份:
      2007
    • 负责人:
      YANAGISAWA Junn
    • 依托单位:
    Analysis of the ubiquitin ligase complexes that regulates the transcription of nuclear receptors.
    • 批准号:
      17054005
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $67.33万
    • 财政年份:
      2005
    • 负责人:
      YANAGISAWA Junn
    • 依托单位:
    Mokecular Mechanism of Nuclear Receptor-mediated Chromatin Remodeling
    • 批准号:
      12672108
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.05万
    • 财政年份:
      2000
    • 负责人:
      YANAGISAWA Junn
    • 依托单位:
    国内基金
    海外基金
    CENPI/NRF2/ALDH3A1 信号轴介导的脂质代谢重编程诱导ER阳性乳腺癌免疫抑制的作用机制研究
    • 批准号:
      JCZRLH202600982
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    基于“郁痰”理论探讨海藻消瘤胶囊调控ERα-PPARγ轴抑制PTC细胞代谢失衡的作用机制
    基于MAMs途径调控ER-phagy探讨肾安汤治疗糖尿病肾病的作用机制
    SWI/SNF介导的表观遗传重塑与ER-α36依赖的信号编程协同调控非小细胞肺癌治疗抵抗的机制研究
    • 批准号:
      2026JJ82016
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      龚灿
    • 依托单位: